ARTICLE

FindCenter AddIcon

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

By Yasemin Saplakoglu — 2019

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Read on www.livescience.com

FindCenter Post-Image

The Autoimmune Spectrum: Does It Exist, and Are You on It?

Autoimmunity—which affects three quarters more women than it does men—encompasses a range of conditions and diseases that involve the immune system mistakenly attacking the body’s own organs, tissues, and cells.

FindCenter AddIcon

EXPLORE TOPIC

Psilocybin